Feature Channels: Blood

Filters close
Newswise: Houston Methodist Ramps up Plasma Therapy as FDA Approves Clinical Trial
Released: 4-Apr-2020 1:40 PM EDT
Houston Methodist Ramps up Plasma Therapy as FDA Approves Clinical Trial
Houston Methodist

The FDA’s announcement Friday to approve convalescent serum therapy as a large-scale clinical trial opened the door for more patients to receive the potentially life-saving gift of a donor’s plasma.

Released: 3-Apr-2020 2:20 PM EDT
Mayo Clinic named national site for Convalescent Plasma Expanded Access Program
Mayo Clinic

Mayo Clinic will be the lead institution providing coordinated access to investigational convalescent plasma for hospitalized patients with severe or life-threatening COVID-19, or those at high risk of progression to severe or life-threatening disease. The Food and Drug Administration (FDA) announced the designation on Friday, April 3.

Newswise: Reaching toward a cure for sickle cell disease
Released: 2-Apr-2020 3:35 PM EDT
Reaching toward a cure for sickle cell disease
Case Western Reserve University

The National Heart, Lung, and Blood Institute (NHLBI) has awarded Case Western Reserve University up to $3.7 million to assess emerging genome-editing based therapies being tested for curing sickle cell disease (SCD) at leading U.S research universities and hospitals. SCD is the most well-known among a group of inherited blood disorders, affecting about 100,000 people in the United States and about 20 million worldwide, according to a 2018 National Institutes of Health (NIH) statement announcing the NHLBI Cure Sickle Cell Initiative.

Newswise: COVID-19 Tip Sheet: Story Ideas from Johns Hopkins
Released: 31-Mar-2020 8:00 AM EDT
COVID-19 Tip Sheet: Story Ideas from Johns Hopkins
Johns Hopkins Medicine

Vaccine expert working on developing covid-19 vaccine, sees major differences between Covid-19 and SARS

Newswise: New blood test can detect wide range of cancers, now available to at risk individuals in clinical study at Dana-Farber
30-Mar-2020 8:25 AM EDT
New blood test can detect wide range of cancers, now available to at risk individuals in clinical study at Dana-Farber
Dana-Farber Cancer Institute

In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute and the Mayo Clinic.

Newswise: FDA Approves First Plasma Therapy for Houston Methodist COVID-19 Patient
Released: 30-Mar-2020 8:30 AM EDT
FDA Approves First Plasma Therapy for Houston Methodist COVID-19 Patient
Houston Methodist

Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside over the weekend as the death toll in the COVID-19 pandemic soared to more than 2,000 people across the United States, with more than 100,000 Americans sick from the virus.

24-Mar-2020 4:05 PM EDT
Insights From Ambulatory Blood Pressure Monitoring in Patients with Kidney Disease
American Society of Nephrology (ASN)

• Two studies examine potential benefits of blood pressure monitoring outside of doctors’ offices for patients with kidney disease.

Released: 23-Mar-2020 2:45 PM EDT
Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course
Mount Sinai Health System

An expert team of researchers and clinicians have been working together to design, validate, and implement an “end-to-end” clinical pathology laboratory solution that will allow for the testing of approximately several hundred people per day in order to rapidly diagnose and help guide the selection of treatment and monitor disease course.


Showing results

110 of 10

close
0.71671